Forced expiratory volume in 1 second (FEV 1 ) from spirometry is the most commonly used parameter to detect early allograft dysfunction after lung transplantation (LTx).
| INTRODUCTION
Lung transplantation (LTx) in children and adolescents is an established treatment option for end-stage lung disease. [1] [2] [3] Despite ongoing progress in the clinical care of these patients, long-term survival remains far from satisfactory, with a median survival of about 6 years. 1 After the first year, chronic lung allograft dysfunction (CLAD) is the main cause of death post-LTx, with bronchiolitis obliterans syndrome (BOS)
being the leading cause of CLAD. 2, 4 Therefore, regular spirometry is recommended in all lung transplant recipients to detect early allograft dysfunction. [5] [6] [7] [8] A major concern is the low sensitivity of forced expiratory volume in 1 second (FEV 1 ) to detect early pathologic processes in the small airways, as well as the need for strong and coordinated breathing maneuvers, which is extremely challenging for smaller children. [6] [7] [8] Studies in adult lung transplant recipients have found that spirometry decline had a sensitivity of only 50-70% to detect allograft rejection. 7 Sensitive lung function tests such as inert gas washout (IGW) techniques are gaining increasing importance for the detection of pathologic processes, especially in the small airways. An example of these tests is the nitrogen multiple breath washout (N 2 -MBW)-an easy, sensitive, and reproducible test for detecting early lung function
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impairment in children and adults with various lung diseases. 5, 6, [9] [10] [11] [12] [13] [14] [15] The main outcome index from N 2 -MBW is the lung clearance index (LCI), which is independent of the lung size and provides information about the global ventilation inhomogeneity. 5, 6, [9] [10] [11] [12] [13] [14] [15] In addition to LCI, a more specific index for diffusion convection-dependent impairment in the small airways is the S acin , which is highly elevated in adults and children with small airways disease. 10, 15 Whether N 2 -MBW is a useful additional tool with which to monitor lung function after transplantation in children and adolescents is not clear yet. 
| MATERIAL AND METHODS

| Study design and study population
This cohort study was carried out with pediatric patients (≤18 years of age) after LTx. All patients (n = 37) were recruited from the out- The cohort of healthy age-matched patients (n = 51) were enrolled at the University Children`s Hospital Bern, Switzerland. Healthy controls had neither a history of chronic lung disease nor acute respiratory infection in the 4 weeks before the investigations and had been included in part as a control group for another study. 
| Ethic statement
The study was approved by the Ethics Committee of the Canton of Bern, Bern, Switzerland, and the Ethics Committee of the Hannover University, Hannover, Germany. We obtained written informed consent from parents and participants older than 16 years. 
| Clinical data
| Nitrogen multiple breath washout
All subjects performed N 2 -MBW with the use of a commercially avail- 
| Spirometry
Spirometry was done using the Jaeger MasterScreen bodyplethysmo- 
| Statistical analysis
Visual inspection of data distribution indicated significant skewing.
Washout variables were expressed as median ± IQR. We calculated zscores from the healthy controls for IGW outcome variables and from recommended reference equations for spirometry. 20, 21 Upper and lower limits of normal (ULN, LLN) were defined as mean ± 1.64 × SD.
20
Continuous variables were compared with the use of the WilcoxonMann-Whitney test, and categorical variables were compared with the use of the χ 2 test, as appropriate. Correlations were described with the use of Spearman rank correlation coefficient (r). Values of P < .05 were considered statistically significant. As appropriate,
Bonferroni correction was used for multiple comparisons. Definition of correlation was defined as weak (0.10 and 0.29), moderate (0.3 and 0.49), and above 0.50 strong. 22 We assessed the intrasubject and intertest variabilities with use of the coefficient of variation 
| RESULTS
Thirty-seven children and adolescents (15 males) aged 7 to 17.9 years after bilateral LTx were included in the study. The median (IQR) age at time of transplantation was 12.9 (9.9-15.1) years. Median (IQR) time posttransplantation at first measurement was 1.6 (0.6-3.0) years.
Main diagnosis leading to LTx was cystic fibrosis (n = 21), followed by pulmonary hypertension (n = 6). All patients received the same immunosuppressive regimen consisting of prednisone, tacrolimus, and mycophenolate. Demographics, patient condition before transplantation, operation type, and postoperative course are summarized in Tables 1, 2 and 3.
| Data
All patients were able to perform technically acceptable N 2 -MBW and spirometry on the same day. After passing quality control, all 37 patients were included for LCI and spirometry calculations from their first (primary) study-related measurements. Four patients had to be excluded from S acin and 3 patients were excluded from S cond calculations due to irregular breathing.
Likewise, all lung function indices from the 28 (75.6%) of 37 patients who had undergone repeat measurement were included for intertest variability analysis. Tables 3 and 4 outline the lung function characteristics. Furthermore, we included the longitudinal lung function data (>7 separate measurements) from 2 additional patients who had established BOS for analysis.
| Primary lung function indices in patients after LTx compared with healthy controls
Outcomes from all IGW measurements differed significantly between healthy controls and transplant patients (Table 3) . Although spirometry was considered stable in the posttransplantation group, it was noted to be abnormal in 11 (30%) and 27 (73%) of the children for FEV 1 /FVC ratios and FEV 1 , respectively. In patients, indices for global and acinar ventilation inhomogeneity were highly and significantly elevated compared with healthy controls (P < .001). LCI z-scores ranged from −1.3 to 21 and were elevated in 30 (81%) of the transplanted children ( Figures 1A, 2, and S1).
Likewise, S acin was elevated in 19 (58%) patients ( Figure 3 ).
We found a poor correlation between LCI and FEV 1 /FVC z-scores (Figures 1 and 2 
| Agreement between primary lung function indices
In terms of congruence with changes in FEV 1 /FVC ratio, only 8 patients had concomitantly pathologic LCI and FEV 1 /FVC ratios, compared with 6 patients with pathologic S acin and FEV 1 /FVC ratios.
Twenty-two patients with FEV 1 /FVC ratios in the normal range had highly elevated LCI, as opposed to 13 patients with elevated S acin .
Decreased FEV 1 /FVC ratios were found in 3 patients with normal LCI and in 4 patients with normal S acin ( Figure S4 ). 
T A B L E 4 Outcome variables of lung function measurements in patients after lung transplantation
| Primary and repeated lung function indices
In all 28 patients with repeated lung function tests, 20 patients had highly elevated LCI values. In 21 patients, the LCI remained abnormal (n = 18) or normal (n = 3) on both occasions, 2 patients worsened within the second test occasion, and 5 patients changed to having normal LCI values. In 7 patients, the S acin remained abnormal or nor- Figure 1B ). There were no significant correlations for either FEV 1 or LCI with sex, height, smoking status of the donor, or transplantation of size-reduced organs (Table S1 ).
| Clinical parameters
Of note, the donor median (IQR).age in our cohort was 15 years. Twenty-two donors were younger than 18 years. At a group level, we did not find a significant difference between donor and recipient for age and height (P = .12; P = .19, respectively). However, at
an individual level, we determined high individual differences (−28 to 
| Patients with BOS
We provide additional longitudinal lung function data from 2 patients with BOS ( Figures 6 and 7) . Both patients died after the last measurement so we cannot provide further data for these patients. However, with these additional data, we demonstrate (1) highly elevated ventilation inhomogeneity indices in both patients, (2) 
| DISCUSSION
| Main findings
This is the first cohort study that uses N 2 -MBW for diagnostic monitoring of lung function in a large cohort of pediatric patients after LTx.
Our primary finding was that we detected highly elevated LCI and S acin values in a relevant number of clinically stable patients on 2 different occasions, which is indicative for persistent small airways impairment. We observed a poor correlation between FEV 1 and LCI and S acin indices. Finally, we showed that the LCI was highly elevated before 
| Comparison with previous literature
Our findings suggest that N 2 -MBW is applicable in lung transplant recipients with low intratest and intertest variabilities. There were a relevant number of clinical stable patients who displayed persistent pathologic N 2 -MBW indices, which might be a sign of irreversible small airways impairment. Furthermore, longitudinal data from 2 patients before and after the development of BOS showed a significant increase in washout indices. These results support the hypothesis that the N 2 -MBW is a useful tool to detect both persistent and new emerging pathologies in the small airways after LTx. 23 This seems promising for both clinical care and medical research. With respect to the histopathologic proclivity of BOS, namely obliterative bronchiolitis (OB), early diagnosis is extremely important because end-stage OB is characterized by treatment-refractory, irreversible fibrosis of the distal bronchioles.
24-26
Current guidelines on the diagnosis and management of BOS after
LTx define BOS as a persistent decline in FEV 1 that is not caused by any other known and potentially reversible causes of posttransplantation loss of lung function. 16 Change in FEV 1 has been the standard by which BOS is defined despite the fact that it is relatively insensitive to changes in the peripheral airways. There are very few studies that have evaluated different lung function parameters for monitoring allograft function after LTx, with the majority having only adult cohorts.
23,25-27
A previous longitudinal study in lung transplanted adults revealed that a concurrent FEV 1 and FVC decline from baseline is associated with fulminant rapid deterioration and a poor prognosis. 28 These results indicate that a combination of different lung function parameters may be more predictive of disease course and prognosis than any single parameter. It is easy to envision that N 2 -MBW is a promising method for providing additional information regarding early pathologic changes in the distal airway. We showed no significant differences between donor and recipient height at a group level but did show high individual differences between the 2 values. The extent to which ventilation inhomogeneity is influenced by the donor organ requires further study. Hence, a Researchers found that S acin is a measure of worsening in ventilation heterogeneity, generated at the level of the acinar entrance. The elevation of S acin in more than 50% of our patients was in accordance with the findings of these adult studies that more specific markers for small airways pathology are often elevated in post-LTx patients who would otherwise be designated as being BOS grade "0" by spirometry (ie, free of BOS). Furthermore, S acin correlated poorly with LCI, which implies that they are measures for different pathologic airway processes. It was beyond the scope of this study to demonstrate whether an elevated LCI and/or S acin in our study's cohort was related to early inflammatory process of the small airways with the potential to progress into BOS or whether they were resultant from any of the other diverse transient or persisting lung injuries during or after LTx. 
| Strengths and limitation
The main strength of our study was its rigorous design. All lung function measurements were always performed on the same day and hence under the same conditions. In addition, the entire large cohort of pediatric lung transplant recipients were recruited and followed up in a single center, with resultant complete conformity in data acquisition because the same equipment and software were used with every case. Further, quality control and analysis were performed by the same investigator for all measurements, eliminating interinvestigator variability. Reproducibility of the LCI was high, because since intratest and intertest variabilities were low.
A limitation was that the time between lung function measurements and LTx ranged from 0.3 to 8 years; however, we found no correlation between the time to measurement and the lung function indices. Therefore, we believe that our results were not affected by the varying times between LTx and the measurement. Unfortunately, 
| CONCLUSION
The results of our study advocate a greater role for N 2 -MBW as a diagnostic tool in monitoring patients after LTx. N 2 -MBW is easy to perform and adjusted for lung size, unlike the traditionally used FEV 1 .
LCI and S acin were elevated during stable phases in the majority of the children after LTx, which may be the result of clinically silent pathologic processes, especially in the small airways. The poor correlation among LCI, S acin , and spirometry indices indicates that they measure separate and potentially complementary information for ventilation inhomogeneity. If so, LCI and S acin could be used for the early detection and treatment of chronic allograft dysfunction before irreversible damage ensues. Clearly, larger longitudinal studies are needed to confirm this hypothesis.
